ALXO: ALX Oncology Holdings Inc. Stock

by  •  • Comments Off on ALXO: ALX Oncology Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 819.09
Enterprise Value ($M) 806.32
Book Value ($M) 189.71
Book Value / Share 3.76
Price / Book 4.32
NCAV ($M) 135.82
NCAV / Share 2.69
Price / NCAV 6.03

Profitability (mra)
Return on Invested Capital (ROIC) -0.78
Return on Assets (ROA) -0.58
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 5.24
Current Ratio 5.24

Balance Sheet (mrq) ($M)
Current Assets 188.66
Assets 242.55
Liabilities 52.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -170.28
Net Income -160.81

Cash Flow Statement (mra) ($M)
Cash From Operations -130.36
Cash from Investing 44.66
Cash from Financing 59.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Orbimed Advisors Llc 4.50 -0.49
02-14 13D/A LSV Associates, LLC 5.90 -29.92
02-14 13G/A Redmile Group, LLC 9.60 -1.65
02-09 13G/A Fmr Llc 15.00 22.24
10-13 13G Cormorant Asset Management, LP 6.31

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 69,250 458,425 15.11
2024-04-24 100,752 120,255 83.78
2024-04-23 61,293 143,843 42.61
2024-04-22 53,050 104,181 50.92

(click for more detail)

Similar Companies
ALLO – Allogene Therapeutics, Inc. ALNY – Alnylam Pharmaceuticals, Inc.
ALVR – AlloVir, Inc. AMGN – Amgen Inc.
AMLX – Amylyx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io